GoHealthcare AI Governance Center
GoHealthcare AI Governance Center
A Twelve Domain Governance Framework for Artificial Intelligence in Musculoskeletal Specialty Practice, Prior Authorization, and Revenue Cycle Operations
What is the GoHealthcare AI Governance Center?
This document is an educational and operational reference. It is not medical advice, legal advice, or a substitute for independent payer policy verification. It does not replace physician clinical judgment, official Centers for Medicare and Medicaid Services guidance, or the advice of qualified counsel.
Document Control
Publication and Review Detail
| Document Control | Detail |
|---|---|
| Document Identifier | GH-MSK-AI-000 |
| Version | 1.0 |
| Effective Date | August 6, 2026 |
| Publication Series | GoHealthcare MSK Specialty Procedure Library -- AI Governance Center |
| Standard Applied | GoHealthcare Clinical Procedure Guide Standard v1.0 |
| Developed By | GoHealthcare Practice Solutions under the leadership of Pinky Maniri, Founder and CEO of GoHealthcare Practice Solutions |
| Credentials | MSc, BSc, CRCR, CSAPM, CSPPM, CSBI, CSPR, CSAF, Certified in Healthcare AI Governance |
| Scope of Review | Federal regulation, state law, accreditation standards, consensus frameworks, payer and utilization management vendor practice, and musculoskeletal specialty operations |
| Primary Audience | Physicians, advanced practice providers, practice administrators, compliance officers, prior authorization and utilization management leaders, revenue cycle leaders, ambulatory surgery center leadership, health system service line executives, and counsel |
| Document Type | Educational and operational reference |
01
GoHealthcare AI Governance Center
Why does healthcare need a dedicated AI governance center for MSK specialty operations?
Original section: Overview
Important Notice
Artificial intelligence law, regulation, and payer policy are changing rapidly. Federal and state requirements described here were verified against primary sources as of the effective date shown above and may have changed since publication. Verify current requirements before acting.
Nothing in this document should be read as an endorsement of any specific artificial intelligence product, vendor, or model.
The GoHealthcare AI Governance Center is the artificial intelligence governance layer of the GoHealthcare MSK Specialty Procedure Library. It exists because musculoskeletal specialty care has become one of the densest concentrations of artificial intelligence in American healthcare operations, and because most of that artificial intelligence is now pointed at the practice rather than operated by it.
Consider what a mid-sized interventional pain and spine practice now faces. Its Medicare prior authorization requests in six states are screened by artificial intelligence and machine learning under a federal payment model. Its commercial requests are triaged by utilization management vendors that use automation to route, screen, and prioritize clinical review. Its ambient documentation tool drafts the operative history and physical. Its clearinghouse scores claims for denial risk before submission. Its imaging vendor runs a computer-assisted detection algorithm across every study. Its patient portal answers scheduling questions with a conversational agent. Its coding vendor proposes codes from the note. None of these were governed decisions in most practices. They arrived embedded inside products the practice already owned.
Governance is the discipline of knowing what artificial intelligence is operating inside an organization, on whose authority, against what performance expectation, with what human accountable for the output, and with what evidence that any of this is working. It is not a technology problem. It is an operations, documentation, compliance, and accountability problem, which is precisely the domain in which GoHealthcare works.
This Center is organized into twelve domains. Each domain is a self-contained Knowledge Center page written to the GoHealthcare Clinical Procedure Guide Standard v1.0. Together they form a complete governance program that a musculoskeletal specialty organization can stand up without hiring a data science team, and that maps cleanly onto the National Institute of Standards and Technology Artificial Intelligence Risk Management Framework, ISO/IEC 42001, and the Joint Commission Responsible Use of AI in Healthcare certification structure.
What This Center Is Not
It is not a data science curriculum, a model development guide, a vendor comparison, or an endorsement of any artificial intelligence product. It does not evaluate the safety or accuracy of any specific tool.
It is not legal advice. Several requirements described here are the subject of active federal preemption effort and active litigation, and at least one state framework was repealed and replaced during the preparation of this Center.
It is not a substitute for the physician review that federal and state law require in utilization management and clinical decision making.
Back to page navigation02
GoHealthcare AI Governance Center
What should healthcare leaders know about AI governance at a glance?
Original section: Governance at a Glance
The executive summary below is the one-page orientation for a leader who needs to understand the artificial intelligence governance obligation before reading further.
| Domain | Position as of August 6, 2026 |
|---|---|
| Federal statute specific to healthcare artificial intelligence | None. There is no single federal artificial intelligence statute governing healthcare providers. Obligations arise from existing law applied to artificial intelligence: nondiscrimination, privacy, device regulation, certification of health information technology, insurance regulation, and conditions of participation. |
| Federal rule most directly binding on providers | Section 1557 nondiscrimination, 45 CFR 92.210, addressing patient care decision support tools. Enforcement posture requires confirmation with counsel. |
| Federal rule most directly binding on technology developers | The HTI-1 decision support intervention certification criterion at 45 CFR 170.315(b)(11), which creates the predictive decision support intervention category and the source attribute transparency set. |
| Artificial intelligence in Medicare prior authorization | Live. The Wasteful and Inappropriate Service Reduction Model operates in six states from January 1, 2026 through December 31, 2031. Human clinician review is required on every non-affirmation. |
| Artificial intelligence in Medicare Advantage utilization management | Permitted as support only. Medical necessity determinations must rest on the individual patient's circumstances and the whole clinical record. An algorithm cannot be the sole basis for denial or termination. |
| State law | Fragmented and unstable. Texas requires disclosure of artificial intelligence use in health care services and practitioner review of artificial intelligence generated diagnostic output. A growing group of states requires a qualified licensed human to own adverse utilization review determinations. Colorado repealed and replaced its framework in May 2026. |
| Federal preemption effort | Active. A December 11, 2025 executive order directs an artificial intelligence litigation task force to challenge state artificial intelligence laws and directs the Department of Commerce to evaluate them. Outcome is unresolved. |
| Accreditation | Voluntary certification is now available. The Joint Commission Responsible Use of AI in Healthcare certification launched June 1, 2026, structured around governance, data management, risk and bias reduction, monitoring and validation, and transparency and training. |
| Consensus frameworks | The National Institute of Standards and Technology framework provides the method. ISO/IEC 42001 provides the certifiable management system. Neither is legally required in the United States. |
| Practical governance obligation today | Maintain a live inventory, assign a named accountable owner to every system, tier by risk, validate before deployment, monitor after deployment, preserve human accountability where law requires it, and keep evidence that all of the above actually happened. |
03
GoHealthcare AI Governance Center
What are the twelve domains of the GoHealthcare AI Governance Center?
Original section: The Twelve Domains of the AI Governance Center
The twelve domains are sequenced deliberately. Domains one through six establish the program. Domains seven through nine operate it. Domains ten through twelve sustain it. An organization starting from zero should work them in order. An organization with an existing program should use the maturity self-assessment in section 5 to find its entry point.
| Sequen ce | Domain | The Question It Answers |
|---|---|---|
| 1 | AI Governance | Who decides, who is accountable, and how are those decisions documented and escalated? |
| 2 | AI Readiness | Is our data, workflow, workforce, and infrastructure capable of supporting artificial intelligence responsibly before we deploy it? |
| 3 | AI Policies | What written policies must exist, what must each say, and who approves and maintains them? |
| 4 | AI Risk Management | How do we identify, tier, assess, control, and monitor artificial intelligence risk in a way an auditor would accept? |
| 5 | AI Ethics | What principles constrain our use of artificial intelligence when the law is silent, and how do we operationalize them? |
| 6 | AI Oversight | What does meaningful human oversight actually look like, and how do we prove it happened? |
| 7 | AI Procurement | How do we evaluate, diligence, and contract for artificial intelligence, and what terms are non-negotiable? |
| 8 | AI Use Cases | Which musculoskeletal specialty use cases are worth pursuing, in what order, and at what risk tier? |
| 9 | AI Implementation | How do we pilot, validate, launch, change-control, and scale without creating uncontrolled risk? |
| 10 | AI Templates | What reusable documents do we need, and what does each one have to contain? |
| 11 | AI Checklists | What are the operational checks at every lifecycle stage? |
| 12 | AI Resources | Where do the authoritative sources live, and how do we keep current when everything changes quarterly? |
04
GoHealthcare AI Governance Center
How are the twelve AI governance domains connected?
Original section: AI Governance Center Navigation Index
The GoHealthcare AI Governance Center is a thirteen page set. The hub landing page and twelve topic pages are written to be read independently, and each is self-contained. Where a topic is developed in depth on another page, this document points to that page rather than duplicating the material. The page currently open is marked.
| Identifier | Page | Coverage |
|---|---|---|
| GH-MSK-AI-000 | AI Governance Center [ THIS PAGE ] | Hub landing page, series map, and how to use the Center |
| GH-MSK-AI-001 | AI Governance | Governance structure, charter, decision rights, and accountability |
| GH-MSK-AI-002 | AI Readiness | Data, workflow, workforce, and infrastructure readiness assessment |
| GH-MSK-AI-003 | AI Policies | The policy stack an MSK organization needs and what each policy says |
| GH-MSK-AI-004 | AI Risk Management | Risk taxonomy, tiering, assessment, controls, and monitoring |
| GH-MSK-AI-005 | AI Ethics | Ethical principles applied to MSK operational and clinical use |
| GH-MSK-AI-006 | AI Oversight | Human oversight, performance monitoring, audit, and escalation |
| GH-MSK-AI-007 | AI Procurement | Vendor evaluation, diligence, contracting, and contract terms |
| GH-MSK-AI-008 | AI Use Cases | Prioritized MSK specialty use cases with risk tier and evidence needs |
| GH-MSK-AI-009 | AI Implementation | Pilot design, validation, go-live, change control, and scaling |
| GH-MSK-AI-010 | AI Templates | Reusable governance document templates and drafting instructions |
| GH-MSK-AI-011 | AI Checklists | Operational checklists across the full artificial intelligence lifecycle |
| GH-MSK-AI-012 | AI Resources | Authoritative primary sources, standards, and monitoring calendar |
Publication note. Child pages of the AI Governance Center are published to reserved Knowledge Center slugs. Until each page is live, internal cross references are rendered as plain text rather than active links, consistent with GoHealthcare library practice of never activating a link to an unpublished page.
Back to page navigation05
GoHealthcare AI Governance Center
How should healthcare leaders use the AI Governance Center?
Original section: How to Use This Center
Governance Maturity Self-Assessment
Answer the following honestly at the executive level before choosing an entry point. Each unchecked item is a specific page in this Center.
- We can produce, within one business day, a complete list of every artificial intelligence system operating in our organization, including systems embedded in products we did not purchase as artificial intelligence.
- Every artificial intelligence system on that list has a named accountable owner who is a person, not a department.
- We have a written, board-approved or executive-approved artificial intelligence policy that staff can find and have been trained on.
- We have a documented risk tier for every artificial intelligence system, and the tier drives the level of oversight applied.
- We validated performance in our own patient population before deployment, not only relying on vendor-reported performance.
- We monitor performance after deployment on a defined cadence, with a defined threshold that triggers action.
- Where law requires a licensed human to make or own a determination, we can prove from the record that a licensed human did so.
- Our vendor contracts address training data, model change notification, performance disclosure, indemnification, and audit rights.
- We disclose artificial intelligence use to patients where state law requires it, in the states where we operate.
- We have a documented process for a clinician or staff member to report a suspected artificial intelligence failure, and evidence that reports were acted upon.
| Items Checked | Maturity Stage | Recommended Entry Point |
|---|---|---|
| 0 to 2 | Unmanaged. Artificial intelligence is in use but not governed. | Start with AI Governance, then AI Policies, then build the inventory using the tools in AI Checklists. |
| 3 to 5 | Emerging. Structure exists on paper but is not operating. | Start with AI Risk Management to build tiering, then AI Oversight to make oversight real and evidenced. |
| 6 to 8 | Operating. The program functions but evidence is thin. | Start with AI Oversight and AI Implementation, then use AI Templates to standardize the artifacts an auditor will ask for. |
| 9 to 10 | Mature. Ready for external validation. | Use AI Resources and AI Templates to prepare for the Joint Commission Responsible Use of AI in Healthcare certification or ISO/IEC 42001. |
A Ninety Day Sequence for an Organization Starting From Zero
| Days | Objective | Deliverable |
|---|---|---|
| 1 to 15 | Name an accountable executive owner and charter the governance body. | Signed charter, named chair, defined membership, defined meeting cadence, defined decision rights and escalation path. |
| 10 to 30 | Build the inventory. Discovery is the hardest step because most artificial intelligence is embedded. | Live inventory with system name, vendor, function, data accessed, clinical or administrative classification, and named owner. |
| 25 to 45 | Tier the inventory by risk. Do not attempt to govern everything at the same intensity. | Risk tier assigned to every system with documented rationale, plus a prioritized list of high tier systems requiring immediate attention. |
| 35 to 60 | Approve the minimum viable policy set. | Approved artificial intelligence use policy, acceptable use standard for generative tools, human oversight standard, and incident reporting procedure. |
| 50 to 75 | Validate and instrument the highest risk systems. | Local validation record, defined performance metrics, monitoring cadence, and action thresholds for each high tier system. |
| 65 to 90 | Train the workforce and close the evidence loop. | Role-based training record, disclosure practice confirmed for each operating state, and first governance body review of the operating program. |
06
GoHealthcare AI Governance Center
Regulatory Baseline Verified as of August 6, 2026
The requirements below were verified against primary sources during preparation of this document. Artificial intelligence regulation is moving faster than any other area GoHealthcare tracks, and several items below are the subject of active litigation, pending amendment, or announced federal preemption effort. Treat this table as a starting point for verification, not as a settled compliance baseline.
| Authority | Instrument | Status and Operational Effect |
|---|---|---|
| Office for Civil Rights, Department of Health and Human Services | Section 1557 nondiscrimination rule, 45 CFR 92.210, patient care decision support tools | Requires covered entities to make reasonable efforts to identify patient care decision support tools that use race, color, national origin, sex, age, or disability as an input variable, and to mitigate the risk of discrimination from those tools. Compliance date was May 1, 2025. A May 13, 2025 nonenforcement announcement addressed subsections 92.210(b) and (c) alongside other provisions. The section remains in the Code of Federal Regulations. Counsel should confirm current enforcement posture before relying on nonenforcement. |
| Assistant Secretary for Technology Policy and Office of the National Coordinator for Health Information Technology | HTI-1 final rule, decision support intervention certification criterion at 45 CFR 170.315(b)(11) | Creates the regulatory category of predictive decision support intervention, defined as technology supporting decision making based on algorithms or models that derive relationships from training data and produce a prediction, classification, recommendation, evaluation, or analysis. Certified health information technology must surface source attributes and developers must conduct intervention risk management. Developer compliance requirements took effect December 31, 2024. The definition reaches large language models and simple risk calculators alike. |
| Centers for Medicare and Medicaid Services, Innovation Center | Wasteful and Inappropriate Service Reduction Model | Six year model, January 1, 2026 through December 31, 2031, operating in New Jersey, Ohio, Oklahoma, Texas, Arizona, and Washington. Model participants use artificial intelligence and machine learning alongside human clinical review. A human clinician must review every non-affirmation. Requests were accepted from January 5, 2026 for dates of service on or after January 15, 2026. Coverage policy itself is unchanged. This is the single most significant live example of artificial intelligence in musculoskeletal prior authorization. |
| Centers for Medicare and Medicaid Services | Medicare Advantage utilization management requirements | Medical necessity determinations must be based on the individual patient's circumstances and the whole clinical record. An algorithm or software tool may support a determination but cannot be the sole basis for denying or terminating coverage. |
| Food and Drug Administration | Artificial intelligence enabled device software functions | Draft guidance on lifecycle management and marketing submission recommendations was published January 6, 2025 and remains draft. Predetermined change control plan guidance for artificial intelligence enabled device software functions is final. The amended device quality system regulation at 21 CFR Part 820 took effect February 2, 2026. |
| Executive Office of the President | Ensuring a National Policy Framework for Artificial Intelligence, December 11, 2025 | Directs the Attorney General to establish an artificial intelligence litigation task force to challenge state artificial intelligence laws, directs Commerce to evaluate state laws, and conditions certain federal broadband funding. Recommended preemption expressly excludes child safety, compute and data center infrastructure, and state government procurement and use of artificial intelligence. Follows Executive Order 14179 of January 23, 2025. |
| State of Colorado | Colorado Artificial Intelligence Act and its replacement | Senate Bill 24-205 was delayed twice and then replaced. A federal court stayed enforcement on April 27, 2026. Senate Bill 26-189, signed May 14, 2026, repeals the original risk-based framework and substitutes a narrower disclosure and rights framework for automated decision-making technology, effective January 1, 2027. Organizations that built a Colorado high-risk compliance program should re-scope rather than decommission. |
| State of Texas | House Bill 149 and Senate Bill 1188 | The Texas Responsible Artificial Intelligence Governance Act took effect January 1, 2026 and requires disclosure to consumers when an artificial intelligence system is used in a health care service or treatment. Senate Bill 1188, effective September 1, 2025, requires that a licensed practitioner review artificial intelligence generated diagnostic output and retain final clinical authority, and restricts offshoring of electronic medical records. |
| Multiple states | Artificial intelligence in utilization review | A growing group of states requires that artificial intelligence may assist utilization review but that a qualified licensed human make or own any adverse medical necessity determination, and that the determination be based on the individual patient's clinical history. California Senate Bill 1120 was among the first. Confirm the specific bill number, effective date, and scope for every state in which the organization operates. |
| Joint Commission and Coalition for Health AI | Responsible Use of AI in Healthcare | Initial guidance was published September 17, 2025. A voluntary Responsible Use of AI in Healthcare certification launched June 1, 2026, organized around governance, effective data management, risk and bias reduction, monitoring and validation of safety and performance, and transparency, education, and training. The certification addresses organizational use of artificial intelligence, not individual products. Joint Commission accreditation is not a prerequisite to apply. |
| National Institute of Standards and Technology | Artificial Intelligence Risk Management Framework and Generative Artificial Intelligence Profile | Voluntary, not certifiable, and organized around the Govern, Map, Measure, and Manage functions. The Generative Artificial Intelligence Profile was added in July 2024. Version 1.0 is under revision, and a concept note for a critical infrastructure profile was released April 7, 2026. Widely used as the method layer beneath certifiable standards. |
| International Organization for Standardization and International Electrotechnical Commission | ISO/IEC 42001 artificial intelligence management system | A certifiable management system standard using the plan, do, check, act model. Commonly paired with the National Institute of Standards and Technology framework as the audit-ready wrapper around a risk-based method. |
Verification Discipline
GoHealthcare does not reconstruct citations from memory. Every item above was checked against a primary or issuing-authority source during preparation. Where a source could not be confirmed, the item is marked as unconfirmed rather than silently populated or omitted.
The state law landscape is the least stable element of this table. Trackers frequently misreport bill numbers, and several widely cited summaries attribute artificial intelligence requirements to bills that regulate something else entirely. Always read the bill, not the tracker.
Back to page navigation07
GoHealthcare AI Governance Center
Scope and Working Definitions
Precise definitions matter because different regulators define the same words differently, and because the wrong definition can put a low-risk administrative tool inside a high-risk governance process, or leave a high-risk clinical tool outside it entirely.
| Term | Working Definition Used Throughout This Center |
|---|---|
| Artificial intelligence system | Any software system that produces a prediction, classification, recommendation, ranking, generation, or decision from data using learned or statistical methods, including systems embedded inside products not marketed as artificial intelligence. |
| Predictive decision support intervention | The regulatory category created by the HTI-1 certification criterion. Technology supporting decision making based on algorithms or models that derive relationships from training data and produce a prediction, classification, recommendation, evaluation, or analysis. It reaches both large language models and simple risk calculators. |
| Patient care decision support tool | The Section 1557 category. Automated and non-automated tools, mechanisms, methods, technologies, or combinations used to support clinical decision making in health programs or activities. It does not reach purely administrative, billing, scheduling, or facilities tools. |
| Generative artificial intelligence | Systems that produce new text, image, audio, or structured content. In musculoskeletal practice this most often means ambient documentation, appeal letter drafting, patient communication drafting, and summary generation. |
| Agentic artificial intelligence | Systems that take multi-step actions in other systems on the organization's behalf, such as submitting an authorization request, posting to the practice management system, or sending a communication. Agentic use raises the risk tier of an otherwise identical model. |
| Human in the loop | A human reviews and must affirmatively act before the output takes effect. The output cannot proceed without the human. |
| Human on the loop | A human monitors outputs and can intervene, but the output proceeds by default. This is not sufficient where law requires a human determination. |
| Meaningful human review | Review by a qualified individual with the information, the time, the authority, and the demonstrated practice of disagreeing with the system. Review that never produces a disagreement is not review; it is a signature. |
| Shadow artificial intelligence | Artificial intelligence in use inside the organization without governance awareness. Most commonly consumer generative tools used by staff on personal accounts and vendor features enabled by default. |
| Model drift | Degradation of performance over time as the population, coding practice, payer policy, or documentation pattern diverges from the conditions under which the model was validated. |
08
GoHealthcare AI Governance Center
Where Artificial Intelligence Touches the Musculoskeletal Authorization and Revenue Cycle
This map is the reason a musculoskeletal specific artificial intelligence governance program is necessary. The generic health system artificial intelligence governance literature is oriented toward inpatient clinical prediction. It largely ignores the stage of the cycle where musculoskeletal specialty practices are most exposed, which is prior authorization and medical necessity.
| Cycle Stage | Where Artificial Intelligence Appears | Governance Consequence |
|---|---|---|
| Referral and intake | Referral triage, insurance discovery, eligibility, benefit and authorization requirement lookup, digital intake. | Low to moderate tier. Errors create administrative rework and access delay rather than clinical harm. Data minimization and vendor diligence are the controls that matter. |
| Clinical encounter and documentation | Ambient documentation, note drafting, coding suggestion from the note, problem list curation. | High tier. The note is the medical necessity evidence. An ambient tool that omits conservative therapy duration, functional deficit, or response to prior injection destroys the authorization case before it is ever submitted. |
| Imaging | Computer-assisted detection, prioritization, measurement, and reporting support on radiography, magnetic resonance imaging, and computed tomography. | High tier and frequently regulated as a device. Confirm clearance status, intended use, and whether the output is being used outside cleared indications. |
| Medical necessity and conservative care determination | Payer and vendor criteria engines, internal criteria checking, gap identification against published policy. | High tier. This is where a false negative causes a denial and a false positive causes a service to be delivered without coverage. |
| Prior authorization submission and adjudication | Wasteful and Inappropriate Service Reduction Model participant screening in six states, utilization management vendor automation, payer intake automation, agentic submission tools. | Highest tier in musculoskeletal specialty. Human clinician review is required on Medicare model non-affirmations, and multiple states require a qualified licensed human to own adverse determinations. |
| Scheduling and surgical coordination | Optimization, block utilization, no-show prediction, cancellation backfill. | Moderate tier. Watch for access equity effects when prediction is used to allocate scarce appointment or block time. |
| Coding and charge capture | Autonomous and assisted coding, charge reconciliation, documentation sufficiency checking. | High tier for compliance rather than clinical risk. Coding certification is voluntary, and the governance question is human accountability for code selection, not the credential of the reviewer. |
| Claim submission and denial management | Pre-submission denial risk scoring, edit prediction, denial categorization, appeal letter generation. | Moderate to high tier. Generated appeal letters that assert facts not in the record are a documented failure mode and a compliance exposure. |
| Patient communication | Conversational agents, portal message drafting, education content generation, outreach. | High tier where clinical content is involved. Multiple states impose disclosure and human contact path requirements on generative clinical communication. |
| Analytics and population management | Risk stratification, remote therapeutic and remote physiologic monitoring analytics, outcome prediction, cohort identification. | Moderate to high tier depending on whether the output drives care allocation. Allocation of scarce resources moves a tool into the Section 1557 patient care decision support tool analysis. |
The Structural Asymmetry
In musculoskeletal specialty care, the most consequential artificial intelligence in the cycle is not owned by the practice. It is operated by payers, by utilization management vendors, and by federal model participants, and it is pointed at the practice's documentation.
This has a direct governance implication that generic frameworks miss. A musculoskeletal artificial intelligence governance program must govern two things: the artificial intelligence the organization deploys, and the organization's readiness to be evaluated by artificial intelligence it does not control. The second is largely a documentation completeness and structure problem, and it is where the return is fastest.
Back to page navigation09
GoHealthcare AI Governance Center
GoHealthcare Clinical Insights
The observations below reflect what GoHealthcare consistently encounters when a musculoskeletal specialty organization begins governing artificial intelligence for the first time.
Discovery Almost Always Doubles the Inventory
The first inventory pass captures what leadership bought. The second pass, which asks vendors directly whether their product contains predictive or generative components and whether any were enabled by default, typically doubles it. Practice management systems, clearinghouses, transcription vendors, patient engagement platforms, and imaging systems routinely contain artificial intelligence features the practice never separately licensed. Send the vendor question in writing and retain the answer.
The Documentation Failure Precedes the Denial
When a practice sees denial rates rise after adopting an ambient documentation tool, the cause is almost never that the tool is inaccurate. It is that the tool produces a clinically adequate note that is an authorization-inadequate note. Conservative therapy is recorded as attempted rather than with modality, duration, and response. Functional deficit is recorded as a narrative rather than a measurable limitation. The fix is a documentation template and a post-generation checklist, not a different vendor.
Human Review Fails Quietly
Where a physician or nurse is required to review an artificial intelligence output, the review degrades toward acceptance within weeks unless something measures it. GoHealthcare recommends tracking the override rate from the first day of deployment. An override rate that falls to near zero is a governance finding requiring investigation, not a sign that the tool is performing well.
Generated Appeals Invent Facts
Appeal letters drafted by generative tools frequently assert conservative therapy, imaging findings, or examination findings that are plausible for the diagnosis but are not present in the record. Submitting an appeal containing an assertion not supported by the medical record is a compliance exposure independent of whether the appeal succeeds. Every generated appeal requires source verification against the record before submission, and the verification must be evidenced.
Staff Are Already Using Consumer Tools
By the time governance begins, staff are typically pasting clinical content into consumer generative tools on personal accounts to draft letters, summarize records, and answer coverage questions. This is a protected health information disclosure event. It is addressed with a sanctioned tool, a clear acceptable use standard, and amnesty for disclosure, not with prohibition alone. Prohibition without a sanctioned alternative drives the practice underground.
Governance Evidence Is the Deliverable
Organizations regularly do the right thing and cannot prove it. The artifact that matters to an auditor, a certifying body, a payer auditor, or opposing counsel is the record: the inventory with dates, the tiering rationale, the validation result, the monitoring log, the override rate, the training completion record, and the incident file. Build the evidence habit at the same time as the practice, not after.
Back to page navigation10
GoHealthcare AI Governance Center
GoHealthcare Leadership Perspective
Artificial intelligence governance in musculoskeletal specialty care is not primarily a technology adoption question. It is a question of whether the organization can continue to demonstrate accountability for its own decisions in an environment where an increasing share of the decision-adjacent work is performed by software.
The competitive reality is asymmetric and worth stating plainly. Payers and utilization management vendors are further along in artificial intelligence deployment than the provider organizations they review, and the federal government has now placed artificial intelligence directly into the Medicare prior authorization pathway for exactly the service categories that define musculoskeletal specialty practice. A practice that responds to this by adopting artificial intelligence tools without governance has increased its exposure without improving its position. A practice that responds by structuring its documentation so that it survives automated review has improved its position regardless of what tools it adopts.
Executives should therefore sequence investment deliberately. The first investment is not a tool. It is inventory, ownership, and documentation structure. Those three produce measurable return in authorization approval rate and denial reduction before a single new system is purchased, and they are the foundation on which every subsequent deployment is safely built.
The second executive obligation is to resist the delegation instinct. Artificial intelligence governance placed entirely inside information technology fails, because the decisions that matter are clinical, operational, and legal. Governance placed entirely inside compliance fails differently, because it
becomes a permission process that the organization routes around. Effective governance in a musculoskeletal organization is chaired by an operational executive, staffed by clinical, revenue cycle, compliance, and information technology leadership, and accountable to the board or ownership on a defined cadence.
The third obligation is to plan for instability. During the twelve months preceding this publication, a state artificial intelligence framework was delayed twice, enjoined, repealed, and replaced; a federal executive order directed litigation against state artificial intelligence laws; a federal payment model placed artificial intelligence into Medicare prior authorization; and a national accrediting body launched a voluntary artificial intelligence certification. Any governance program built around a single jurisdiction's current requirements will be obsolete within a year. Build the program around durable practices, which are inventory, ownership, tiering, validation, monitoring, human accountability, disclosure, and evidence. Those survive regulatory change. Specific citations do not.
Finally, leadership should recognize what artificial intelligence governance signals to the market. Referring physicians, hospital partners, payers negotiating value-based arrangements, and acquirers conducting diligence are all beginning to ask how artificial intelligence is governed. An organization that can answer with a charter, an inventory, a tiering methodology, and a monitoring record is differentiated. One that cannot is increasingly difficult to underwrite.
Back to page navigation11
GoHealthcare AI Governance Center
GoHealthcare Prior Authorization Insight
This section is specific to the intersection of artificial intelligence and musculoskeletal prior authorization, which is the area in which GoHealthcare operates most directly and the area least addressed by general artificial intelligence governance literature.
Write for Two Readers
Every medical necessity narrative now has two audiences: a clinician who reads for clinical coherence, and an automated screen that extracts structured elements. Documentation that satisfies the first and not the second produces avoidable non-affirmations. The elements an automated screen looks for are duration, frequency, modality, measured functional deficit, objective examination findings, imaging correlation to the treated level or compartment, and response to each prior intervention. Write these as discrete, labeled, and dated statements rather than embedding them in narrative prose.
Structure Beats Volume
A longer note is not a better note in an automated review environment. Practices that submit voluminous unstructured records experience higher non-affirmation rates than practices that submit a shorter, structured packet with a labeled medical necessity statement. Build a submission template that presents the required elements in the order the applicable policy states them.
Track Non-Affirmation Reasons as Data
Categorize every non-affirmation by the specific criterion that was not met, not by the payer's summary language. Within one quarter this produces a ranked list of documentation gaps that is far more actionable than any denial report a vendor will provide, and it is the input that makes any subsequent artificial intelligence investment worthwhile.
Use the Peer to Peer Deliberately
In the Wasteful and Inappropriate Service Reduction Model, resubmission is permitted without limit and peer to peer review is available following a non-affirmation, with the original unique tracking
number required on resubmission. Practices that treat the first non-affirmation as final leave recoverable volume on the table. Practices that resubmit without correcting the identified deficiency simply repeat the outcome. The operational discipline is to correct, document the correction, and resubmit.
Do Not Automate Submission Before Automating Verification
Agentic tools that submit authorization requests without a verification step will submit incomplete packets at scale. The correct sequence is to automate the completeness check first and the submission second. A practice that automates submission first converts a manual error rate into an automated error rate.
Never Let Automation Own an Adverse Determination
This applies to organizations that perform utilization review functions, including managed service organizations, risk-bearing entities, and practices operating under delegated arrangements. Federal Medicare Advantage requirements and a growing group of state laws require that a qualified licensed human make or own any adverse medical necessity determination and that the determination reflect the individual patient's circumstances. The evidence of that human determination must be in the record, contemporaneous, and attributable to a named licensed individual.
Back to page navigation12
GoHealthcare AI Governance Center
GoHealthcare Case Study
Fictional Composite
The following case study is an original educational composite created for instructional purposes. It does not describe any actual patient, practice, health system, payer, vendor, or employee. Any resemblance to an actual person or organization is coincidental.
Case Study: Governing What Was Already Running
Clinical and Operational Scenario
A twenty-two physician interventional pain and spine group operates four clinical sites and a wholly owned single-specialty ambulatory surgery center in a state participating in the Wasteful and Inappropriate Service Reduction Model. Annual volume includes approximately six thousand image-guided injections, four hundred radiofrequency ablation sessions, one hundred sixty spinal cord stimulator trials, and a growing peripheral nerve stimulation program. The group's chief executive asks the compliance officer a simple question following a board discussion: how much artificial intelligence are we using? The compliance officer answers that the group uses one ambient documentation tool. That answer is wrong.
Documentation Challenges
- A structured discovery process, consisting of a written vendor questionnaire sent to every technology vendor and a staff survey offering amnesty for disclosure, identifies eleven artificial intelligence systems in operation.
- The ambient documentation tool is confirmed and is the only system leadership knew about.
- The practice management vendor had enabled a no-show prediction feature by default fourteen months earlier.
- The clearinghouse applies a proprietary denial risk score to every claim before submission and suppresses some claims for internal review without notifying the practice.
- The imaging partner runs a computer-assisted detection algorithm on all magnetic resonance imaging studies.
- The patient engagement platform answers inbound portal questions with a conversational agent, including questions about post-procedure symptoms.
- The coding vendor uses a model to propose codes from the note.
- Four staff members in the authorization department are pasting de-identified clinical summaries into a consumer generative tool on personal accounts to draft appeal letters. Review of three letters shows that the summaries were not adequately de-identified.
- No system has a named owner. No system has been validated locally. No system is monitored. There is no artificial intelligence policy.
Prior Authorization Barriers
In parallel, the group's Medicare non-affirmation rate under the federal model has run materially above its historical commercial denial rate for the same services. Categorization of ninety consecutive non-affirmations by specific unmet criterion shows that sixty-one percent cite inadequate documentation of conservative therapy, and that in fifty-four of those sixty-one cases conservative therapy had in fact been delivered and was documented, but as unstructured narrative without modality, duration, or measured response. The documentation was clinically adequate and structurally invisible.
Payer and Regulatory Considerations
- The federal model requires human clinician review of every non-affirmation, which means the group's remedy is procedural rather than adversarial: correct the deficiency, document the correction, resubmit with the original unique tracking number, and use peer to peer review where the criterion interpretation is genuinely contested.
- The undisclosed conversational agent answering clinical portal questions raises a disclosure exposure in states that require notification when artificial intelligence is used in a health care service, and a human contact path requirement in states that regulate generative clinical communication.
- The consumer generative tool use is a protected health information disclosure requiring privacy officer assessment.
- The computer-assisted detection algorithm requires confirmation of clearance status and intended use.
- The clearinghouse claim suppression is a contract and transparency issue rather than a clinical one, but it materially affects revenue and was invisible to the group.
Operational Workflow Response
- A governance body is chartered within three weeks, chaired by the chief operating officer, with the medical director, revenue cycle director, compliance officer, information technology lead, and the authorization department manager as standing members.
- Every identified system receives a named individual owner and a risk tier. The ambient documentation tool, the imaging algorithm, the conversational agent, and the coding proposal tool are tiered high. The no-show prediction and denial risk scoring are tiered moderate.
- A sanctioned enterprise generative tool with a business associate agreement replaces consumer tool use within thirty days, paired with an acceptable use standard and mandatory training.
- The conversational agent is reconfigured to disclose that it is an automated system, to provide a human contact path, and to route any message containing clinical symptom content to a nurse queue rather than answering it.
- The documentation deficiency is addressed with a structured conservative therapy element in the encounter template, requiring modality, start date, duration, frequency, and measured response, combined with a pre-submission completeness check performed before the authorization request leaves the practice.
- Override rate tracking is instituted for the ambient documentation tool and the coding proposal tool from the date of the governance charter.
Resolution Strategy
The group does not decommission any system. It governs all of them. The single highest-return intervention is not artificial intelligence at all: it is the structured conservative therapy element and the pre-submission completeness check, which cost nothing beyond template configuration and workflow discipline.
Outcome
- Discovery moved the known inventory from one system to eleven, and the follow-up vendor questionnaire cycle at ninety days identified two additional embedded features that had been enabled after the initial pass, confirming that inventory is a continuous process rather than a project.
- The documented non-affirmation reason concentration gave the group a single, specific, correctable target rather than a diffuse sense that denials were increasing.
- Override rate tracking on the coding proposal tool identified within two months that overrides had fallen to nearly zero in one department, triggering a targeted retraining and a re-audit.
- The consumer generative tool disclosure was assessed by the privacy officer and handled under the group's existing breach analysis process. The amnesty framing produced honest reporting, which is the reason the exposure was identified at all.
- The group elected to pursue voluntary artificial intelligence certification in the following fiscal year, having concluded that the governance artifacts it now maintained were most of the requirement.
Lessons Learned
- Ask the vendor in writing. Leadership's understanding of what artificial intelligence the organization uses is systematically incomplete, and the gap is embedded vendor features.
- Offer amnesty for shadow use. Prohibition without a sanctioned alternative and without amnesty produces silence, not compliance.
- The highest-return artificial intelligence intervention is often documentation structure rather than a tool.
- Categorize non-affirmations by specific unmet criterion. Payer summary language is not a diagnosis.
- Instrument human review from day one. An override rate that disappears is the earliest available signal that oversight has become ceremonial.
- Inventory is a process, not a project. Schedule the vendor questionnaire on a recurring cadence.
13
GoHealthcare AI Governance Center
GoHealthcare Best Practices
| Practice | What Good Looks Like |
|---|---|
| Name a single accountable executive | One named executive owns artificial intelligence governance organization-wide and reports to the board or ownership on a defined cadence. Committees advise; a person is accountable. |
| Maintain a live inventory | The inventory is updated when systems are added, changed, or decommissioned, and is refreshed by a recurring written vendor questionnaire. It is not an annual spreadsheet exercise. |
| Tier before you govern | Governance intensity is proportional to risk tier. Attempting to apply high-tier controls to every system guarantees the program collapses under its own weight. |
| Validate locally before deployment | Vendor-reported performance is a starting point, not evidence. Validate in the organization's own population, on the organization's own documentation patterns, against the organization's own payer mix. |
| Instrument human oversight | Track override rate, escalation rate, and time-to-review from the first day. Oversight that is not measured degrades predictably. |
| Contract for transparency and change notification | Require notice of material model changes, disclosure of performance characteristics, audit rights, and clear allocation of liability. Silent model updates are the single most common vendor governance failure. |
| Disclose where required, and consider disclosing where not | Confirm state disclosure obligations for every operating state. Where disclosure is not required, weigh whether non-disclosure would surprise the patient. Surprise is the reputational risk. |
| Sanction a tool rather than only prohibiting tools | Provide an approved generative tool with appropriate contractual protections. Staff will use something; govern what they use. |
| Keep the evidence | Every governance decision produces an artifact with a date and a name. The artifact, not the intention, is what withstands review. |
| Re-verify the regulatory baseline quarterly | Artificial intelligence law changed materially four times in the twelve months preceding this publication. Set a standing quarterly review with a named owner. |
14
GoHealthcare AI Governance Center
What are the common mistakes?
Original section: Common Mistakes
| Mistake | Why It Fails | Correction |
|---|---|---|
| Treating governance as an information technology project | The consequential decisions are clinical, operational, and legal. Information technology cannot make them and should not be asked to. | Charter governance under an operational executive with clinical, revenue cycle, compliance, and information technology membership. |
| Inventorying only what was purchased as artificial intelligence | Most artificial intelligence in a specialty practice arrived embedded in products bought for another purpose. | Send a written questionnaire to every technology vendor asking specifically about predictive and generative components and default-enabled features. |
| Relying on vendor performance claims | Vendor performance is measured in the vendor's validation population, which is rarely the organization's population. | Require local validation before deployment and document the result. |
| Prohibiting generative tools without providing one | Staff need the capability and will obtain it outside governance, creating uncontrolled protected health information disclosure. | Sanction an enterprise tool with a business associate agreement, publish an acceptable use standard, and train. |
| Assuming a human signature equals human review | Review degrades to acceptance quickly and invisibly. | Measure override rate and investigate when it approaches zero. |
| Automating submission before automating verification | Converts a manual error rate into an automated error rate at scale. | Automate the completeness check first, submission second. |
| Submitting generated appeals without source verification | Generative tools assert clinically plausible facts that are not in the record. Submitting them is a compliance exposure. | Require and evidence verification of every generated assertion against the record before submission. |
| Building the program around one state's current law | The state landscape is unstable and subject to active federal preemption effort. | Build around durable practices and treat specific citations as a quarterly maintenance item. |
| Governing everything at the same intensity | The program becomes a bottleneck, the organization routes around it, and governance becomes nominal. | Tier by risk and apply proportionate control. |
| Doing the work without keeping the evidence | An unevidenced control does not exist for purposes of audit, certification, payer review, or litigation. | Define the artifact for every control at the time the control is designed. |
15
GoHealthcare AI Governance Center
What are the most important implementation pearls and pitfalls?
Original section: Pearls and Pitfalls
Pearls
- The fastest measurable return in a musculoskeletal artificial intelligence program is usually structured conservative therapy documentation, which requires no artificial intelligence at all.
- Override rate is the single most informative governance metric available and costs almost nothing to collect.
- A written vendor questionnaire is more effective at discovery than any technical scanning approach, because embedded features are a contractual fact before they are a technical one.
- Amnesty produces honest shadow-use reporting. Enforcement-first produces silence.
- Categorizing non-affirmations by specific unmet criterion converts a diffuse denial problem into a short, ranked, correctable list.
- Voluntary certification requirements and good governance practice have converged closely enough that an organization building the program well is building most of the certification evidence incidentally.
Pitfalls
- Silent model updates. A vendor can change model behavior without notice unless the contract requires notification, which invalidates prior local validation without any visible signal.
- Definitional drift. The Section 1557 patient care decision support tool category and the certification program predictive decision support intervention category are not the same set, and a tool can fall in
one and not the other.
- Assuming administrative tools are out of scope. A scheduling tool that allocates scarce surgical block time is making an allocation decision with access equity consequences.
- Confusing nonenforcement with repeal. A regulatory provision under a nonenforcement announcement generally remains in the Code of Federal Regulations and remains subject to change in enforcement posture.
- Treating the federal model as a denial program. It is a prior authorization and pre-payment review program with unlimited resubmission and peer to peer review available, and it is worked procedurally.
- Relying on secondary trackers for state law. Bill numbers are frequently misreported, and at least one widely cited tracker has attributed artificial intelligence requirements to unrelated legislation.
- Allowing governance to become a permission desk. If the only function is approval, the organization will route around it and governance will lose visibility of exactly the deployments it most needs to see.
16
GoHealthcare AI Governance Center
What are the most frequently asked questions about gohealthcare ai governance center?
Original section: Frequently Asked Questions
The questions below are drawn from the questions GoHealthcare is actually asked by musculoskeletal specialty practices, ambulatory surgery centers, and health system service lines.
Q1. Do we have a legal obligation to have an artificial intelligence governance program?
There is no single federal statute requiring a healthcare provider to maintain an artificial intelligence governance program. Obligations arise indirectly and cumulatively: nondiscrimination requirements applicable to patient care decision support tools, privacy and business associate obligations, state disclosure and utilization review requirements, professional licensure and scope requirements, device regulation where applicable, and contractual obligations to payers and partners. In practice, satisfying those obligations without a governance program is not achievable at any meaningful scale. Confirm the applicable requirements with counsel for the specific jurisdictions in which the organization operates.
Q2. What exactly counts as an artificial intelligence system for inventory purposes?
For inventory purposes, define it broadly: any software that produces a prediction, classification, recommendation, ranking, generation, or decision from data using learned or statistical methods. Include embedded vendor features. It is far easier to inventory broadly and then tier aggressively than to defend a narrow inventory definition to an auditor after an incident.
Q3. Our practice does not use artificial intelligence. Does this Center apply?
Almost certainly yes, for two reasons. First, discovery reliably finds embedded artificial intelligence in practice management, clearinghouse, transcription, imaging, and patient engagement products that were not purchased as artificial intelligence. Second, in six states Medicare prior authorization for core musculoskeletal services is now screened using artificial intelligence and machine learning regardless of what the practice itself uses. The organization is inside an artificial intelligence environment whether or not it operates artificial intelligence.
Q4. Does the federal model mean a computer denies our Medicare authorizations?
No. The model uses artificial intelligence and machine learning alongside human clinical review, and a human clinician must review every non-affirmation. Coverage policy itself is unchanged, resubmission is permitted without limit, peer to peer review is available, and normal Medicare appeal rights are preserved. The operational implication is that documentation must be structured to survive an automated first pass, not that determinations are fully automated.
Q5. Can artificial intelligence make a medical necessity denial?
Not as the sole basis. Medicare Advantage requirements provide that medical necessity determinations must be based on the individual patient's circumstances and the whole clinical record and that an algorithm cannot be the sole basis for denying or terminating coverage. A growing group of states imposes parallel requirements for licensed human ownership of adverse determinations. Organizations performing delegated utilization review must be able to prove from the record that a qualified licensed human made the determination.
Q6. Do we have to tell patients we use artificial intelligence?
It depends on the state and the use. Texas requires disclosure when an artificial intelligence system is used in a health care service or treatment. Several states impose disclosure and human contact path requirements on generative artificial intelligence used in clinical communication, generally with an exemption where a licensed human reviews the communication before it is sent. Confirm the requirement for every state in which the organization operates, and consider disclosing voluntarily where non-disclosure would surprise the patient.
Q7. Is the Colorado Artificial Intelligence Act something we still need to comply with?
The original framework was delayed twice, its enforcement was stayed by a federal court on April 27, 2026, and Senate Bill 26-189, signed May 14, 2026, repealed it and substituted a narrower disclosure and rights framework for automated decision-making technology effective January 1, 2027. Organizations that built a Colorado high-risk program should re-scope toward the disclosure framework rather than decommission the underlying governance, which remains useful. Confirm current status with counsel before acting, because this area has changed repeatedly.
Q8. What is the difference between the National Institute of Standards and Technology framework and ISO/IEC 42001?
The National Institute of Standards and Technology Artificial Intelligence Risk Management Framework is a voluntary method organized around the Govern, Map, Measure, and Manage functions. There is no certification against it. ISO/IEC 42001 is a certifiable management system standard using the plan, do, check, act model. Most organizations use the framework as the working method and the standard as the audit-ready wrapper. Neither is legally required in the United States.
Q9. Should we pursue the Joint Commission artificial intelligence certification?
It is voluntary, it launched June 1, 2026, and Joint Commission accreditation is not a prerequisite to apply. It certifies organizational use and governance of artificial intelligence rather than individual products. Its five areas are governance, effective data management, risk and bias reduction, monitoring and validation of safety and performance, and transparency, education, and training. The practical answer for most musculoskeletal specialty organizations is to build the program first; the certification decision becomes straightforward once the artifacts exist.
Q10. Can we use a consumer generative tool if we remove patient identifiers?
De-identification is a technical standard, not an intention. In GoHealthcare's experience, clinical summaries pasted into consumer tools by well-meaning staff routinely retain identifiers, and narrow diagnoses combined with dates and geography can be re-identifying even without obvious identifiers. The defensible answer is a sanctioned enterprise tool governed by a business associate agreement, paired with a clear acceptable use standard.
Q11. Who should own artificial intelligence governance in a specialty practice?
An operational executive, most commonly the chief operating officer or practice administrator, chairing a body that includes the medical director or a designated physician champion, revenue cycle leadership, compliance, information technology, and the prior authorization function. Ownership by information technology alone or compliance alone is the most common structural failure.
Q12. How often should the governance body meet?
Monthly during the first year while the inventory and policy set are being built, then quarterly with an ability to convene on demand for a new deployment, a material vendor change, or an incident. A standing quarterly regulatory review should be on the agenda permanently.
Q13. What is the minimum viable policy set?
Four documents: an artificial intelligence use policy establishing scope, ownership, and approval; an acceptable use standard for generative tools; a human oversight standard defining what review means for each risk tier; and an incident reporting procedure. Everything else can be built after these four are approved and trained.
Q14. How do we validate a tool without a data science team?
Local validation in a specialty practice is usually a structured retrospective comparison rather than a statistical study: take a defined sample of the organization's own recent cases, run the tool, compare against the known correct answer determined by a qualified human, and document agreement, disagreement, and the pattern of disagreement. This is within the capability of any organization that can pull a chart sample, and it is far more informative than a vendor performance sheet.
Q15. What performance metrics should we monitor after deployment?
At minimum: override rate, escalation rate, a use-case-specific accuracy or agreement measure, throughput or time saved, and a fairness or disaggregated performance measure where the tool touches patient care or resource allocation. Define the action threshold before deployment, not after a problem appears.
Q16. What happens if we discover an artificial intelligence system has been producing incorrect output?
Follow the incident procedure: contain by suspending or adding mandatory human review, determine the scope and time window of affected outputs, assess patient safety and privacy consequences, notify the vendor in writing, involve compliance and counsel, remediate affected cases, and document the entire sequence. Do not resume use without documented revalidation and governance body approval.
Q17. Does ambient documentation create compliance risk?
The dominant risk in musculoskeletal practice is not fabrication; it is omission of the elements that establish medical necessity. Ambient tools produce clinically coherent notes that frequently lack structured conservative therapy duration, measured functional deficit, and documented response to prior intervention. The control is a template requirement plus a post-generation completeness check, combined with attestation practice confirmed with counsel.
Q18. Can artificial intelligence write our appeal letters?
It can draft them. It cannot be permitted to assert facts. Every clinical assertion in a generated appeal must be verified against the medical record before submission, and the verification must be evidenced. Submitting an appeal containing an assertion unsupported by the record is a compliance exposure regardless of the appeal outcome.
Q19. How do we handle artificial intelligence that a payer or vendor uses on us?
Govern readiness rather than the tool. Structure documentation so that it presents the required elements in the order and format the applicable policy states them, categorize non-affirmations by specific unmet criterion, use resubmission and peer to peer review deliberately, and track outcomes as data. The organization cannot govern the payer's model; it can govern how well its own record performs under review.
Q20. How do we keep this current when everything changes?
Assign a named owner for regulatory monitoring, set a standing quarterly review, subscribe to primary sources rather than secondary trackers, and maintain the monitoring calendar published in the AI Resources page of this Center. Build the program around durable practices so that regulatory change requires updating citations rather than rebuilding the program.
Q21. Do we need artificial intelligence specific insurance coverage?
This is a question for the organization's broker and counsel. The relevant inquiry is whether existing professional liability, cyber, and technology errors and omissions coverage responds to a claim arising from artificial intelligence output, and how vendor indemnification interacts with those policies. Raise it during procurement rather than after an incident.
Q22. Is there a role for artificial intelligence in the ambulatory surgery center specifically?
Yes, principally in scheduling and block optimization, supply and implant utilization analytics, case costing, documentation completeness checking before the authorization request, and infection and quality surveillance. Ambulatory surgery center governance should also account for the fact that implant and device authorization requirements are among the most documentation-sensitive in musculoskeletal care, which raises the value of pre-submission completeness checking specifically.
Back to page navigation17
GoHealthcare AI Governance Center
What are the key takeaways for healthcare leaders?
Original section: Key Takeaways
- Artificial intelligence is already operating inside most musculoskeletal specialty organizations, largely embedded in products purchased for other purposes and largely ungoverned.
- There is no single federal healthcare artificial intelligence statute. Obligations arise from existing law applied to artificial intelligence, plus an unstable and rapidly changing state landscape now subject to active federal preemption effort.
- Artificial intelligence entered Medicare prior authorization for core musculoskeletal services on January 1, 2026 in six states, with human clinician review required on every non-affirmation and coverage policy unchanged.
- The most consequential artificial intelligence facing a musculoskeletal practice is operated by payers and vendors, not by the practice. Governance must therefore address both what the organization deploys and how well its documentation performs under automated review.
- Human accountability is not delegable. Where law requires a qualified licensed human to make or own a determination, an automated output does not satisfy the requirement regardless of its quality.
- The durable governance practices are inventory, ownership, tiering, validation, monitoring, human accountability, disclosure, and evidence. These survive regulatory change; specific citations do not.
- Voluntary certification is now available and its structure closely tracks good governance practice, meaning an organization building the program well accumulates most of the certification evidence incidentally.
- The evidence artifact, not the intention, is what withstands audit, certification review, payer audit, and litigation.
18
GoHealthcare AI Governance Center
What should healthcare leaders monitor next in artificial intelligence governance?
Original section: Future Outlook
Four trajectories will shape musculoskeletal artificial intelligence governance over the next twenty-four months. Each is presented with its current state and its operational implication rather than as prediction.
Federal Preemption Versus State Fragmentation
The December 11, 2025 executive order directs litigation against state artificial intelligence laws and a Department of Commerce evaluation of them, while expressly excluding child safety, compute and data center infrastructure, and state government procurement from its recommended preemption scope. Whether state healthcare artificial intelligence requirements, particularly utilization review requirements, are targeted remains unresolved. The operational implication is that organizations should build to the most protective standard among their operating states rather than optimizing to the least, because the direction of change is not predictable and the cost of over-compliance is low.
Expansion of Artificial Intelligence in Medicare Prior Authorization
The federal model runs through December 31, 2031 and a gold carding feature exempting providers with consistent affirmation histories has been signaled. If gold carding is implemented as described, documentation quality converts directly into administrative burden reduction, which changes the economics of documentation investment substantially. Organizations should track their own affirmation rate as a strategic metric, not only an operational one.
Convergence of Certification and Governance
The voluntary certification launched in June 2026, the associated governance playbooks, the National Institute of Standards and Technology framework, and ISO/IEC 42001 are converging on a common structure: governance, data management, risk and bias control, monitoring and validation, and transparency and training. Organizations should expect that structure to become the de facto expectation in payer contracting and partnership diligence before it becomes a regulatory requirement.
Agentic Systems and the Accountability Question
The next deployment wave in revenue cycle and authorization operations is agentic: systems that act in other systems rather than only producing output for a human to act upon. Agentic deployment materially raises the risk tier of an otherwise identical model, because the human review step that governance depends upon is precisely what agentic design removes. Organizations should establish, before agentic deployment rather than after, what actions an agent may take unattended, what actions require affirmative human authorization, and how the action record is preserved for audit.
Back to page navigation19
GoHealthcare AI Governance Center
Which authoritative sources support this guidance?
Original section: References
- Centers for Medicare and Medicaid Services. Wasteful and Inappropriate Service Reduction (WISeR) Model. Website: https://www.cms.gov/priorities/innovation/innovation-models/wiser
- Centers for Medicare and Medicaid Services. WISeR Model Provider and Supplier Operational Guide. Website: https://www.cms.gov/priorities/innovation/files/wiser-provider-supplier-guide.pdf
- Centers for Medicare and Medicaid Services. Health Technology Ecosystem initiative. Website: https://www.cms.gov/initiatives/health-technology-ecosystem/overview
- Department of Health and Human Services, Office for Civil Rights. Nondiscrimination in Health Programs and Activities, final rule, 89 Federal Register 37522, May 6, 2024. Website: https://www.federalregister.gov/documents/2024/05/06/2024-08711/nondiscrimination-in-health-programs-and-activities
- Electronic Code of Federal Regulations. 45 CFR 92.210, Nondiscrimination in the use of patient care decision support tools. Website: https://www.ecfr.gov/current/title-45/subtitle-A/subchapter-A/part-92/subpart-C/section-92.210
- Assistant Secretary for Technology Policy and Office of the National Coordinator for Health Information Technology. Decision Support Interventions certification criterion, 45 CFR 170.315(b)(11), test method. Website: https://healthit.gov/test-method/decision-support-interventions/
- Assistant Secretary for Technology Policy and Office of the National Coordinator for Health Information Technology. HTI-1 Decision Support Interventions fact sheet. Website: https://www.healthit.gov/sites/default/files/page/2023-12/HTI-1_DSI_fact%20sheet_508.pdf
- Assistant Secretary for Technology Policy and Office of the National Coordinator for Health Information Technology. Health IT Certification Program Resource Guide, Decision Support Interventions criterion. Website: https://healthit.gov/wp-content/uploads/2024/05/DSI-Criterion-Resource-Guide_508.pdf
- Food and Drug Administration. Artificial Intelligence in Software as a Medical Device. Website: https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-software-medical-device
- Food and Drug Administration. Artificial Intelligence-Enabled Device Software Functions: Lifecycle Management and Marketing Submission Recommendations, draft guidance, January 6, 2025. Website: https://www.fda.gov/media/184856/download
- National Institute of Standards and Technology. Artificial Intelligence Risk Management Framework. Website: https://www.nist.gov/itl/ai-risk-management-framework
- Joint Commission. Responsible Use of AI in Healthcare certification. Website: https://www.jointcommission.org/en-us/certification/responsible-use-of-ai-in-healthcare
- Joint Commission and Coalition for Health AI. Guidance on Responsible Use of AI in Healthcare, September 17, 2025. Website: https://www.jointcommission.org/en-us/knowledge-library/news/2025-09-jc-and-chai-release-initial-guid ance-to-support-responsible-ai-adoption
- Coalition for Health AI. Website: https://www.chai.org
- Colorado General Assembly. Senate Bill 24-205, Consumer Protections for Artificial Intelligence. Website: https://leg.colorado.gov/bills/sb24-205
- Texas Legislature Online. House Bill 149, Texas Responsible Artificial Intelligence Governance Act. Website: https://capitol.texas.gov
- Congressional Research Service. Overview of the Medicare Wasteful and Inappropriate Service Reduction (WISeR) Model, IF13133. Website: https://www.congress.gov/crs-product/IF13133
- American Medical Association. Augmented intelligence in medicine. Website: https://www.ama-assn.org/practice-management/digital-health/augmented-intelligence-medicine
- American Medical Association. State legislative update on artificial intelligence in health care. Website: https://www.ama-assn.org/system/files/issue-brief-state-legislative-update-ai-health-care.pdf
- International Organization for Standardization. ISO/IEC 42001 artificial intelligence management system. Website: https://www.iso.org/standard/42001
- Executive Office of the President. Ensuring a National Policy Framework for Artificial Intelligence, December 11, 2025. Website: https://www.federalregister.gov
- Executive Office of the President. Executive Order 14179, Removing Barriers to American Leadership in Artificial Intelligence, January 23, 2025. Website: https://www.federalregister.gov
- North American Spine Society. Coverage policy recommendations. Website: https://www.spine.org
- American Society of Interventional Pain Physicians. Website: https://www.asipp.org
- American Academy of Orthopaedic Surgeons. Website: https://www.aaos.org
- American Association of Neurological Surgeons. Website: https://www.aans.org
20
GoHealthcare AI Governance Center
Reading Recommendations
The sources below are recommended for readers who need to go deeper than this page. Only authoritative primary sources, standards bodies, accrediting organizations, professional societies, and peer-reviewed literature are listed.
1. Joint Commission and Coalition for Health AI. Guidance on Responsible Use of AI in Healthcare. The foundational organizational governance document for United States health systems. Website: https://www.jointcommission.org
2. National Institute of Standards and Technology. Artificial Intelligence Risk Management Framework and the Generative Artificial Intelligence Profile. The most practical method layer available. Website: https://www.nist.gov/itl/ai-risk-management-framework
3. Centers for Medicare and Medicaid Services. WISeR Model Provider and Supplier Operational Guide. Required reading for any practice in a participating state. Website: https://www.cms.gov
4. Congressional Research Service. Overview of the Medicare Wasteful and Inappropriate Service Reduction Model. A concise, non-advocacy summary. Website: https://www.congress.gov/crs-product/IF13133
5. American Medical Association. Augmented intelligence in medicine policy and the state legislative update on artificial intelligence in health care. Website: https://www.ama-assn.org
6. Assistant Secretary for Technology Policy. Health IT Certification Program Resource Guide for the Decision Support Interventions criterion. The clearest available explanation of the predictive decision support intervention category. Website: https://www.healthit.gov
Back to page navigation21
GoHealthcare AI Governance Center
Related GoHealthcare Resources
The following GoHealthcare Knowledge Center resources are the closest operational companions to this page. Links become active as each page is published.
| Identifier | Resource | Relationship |
|---|---|---|
| GH-MSK-AI-001 | AI Governance | Governance structure, charter, decision rights, and accountability |
| GH-MSK-AI-002 | AI Readiness | Data, workflow, workforce, and infrastructure readiness assessment |
| GH-MSK-AI-003 | AI Policies | The policy stack an MSK organization needs and what each policy says |
| GH-MSK-AI-004 | AI Risk Management | Risk taxonomy, tiering, assessment, controls, and monitoring |
| GH-MSK-AI-005 | AI Ethics | Ethical principles applied to MSK operational and clinical use |
| GH-MSK-AI-006 | AI Oversight | Human oversight, performance monitoring, audit, and escalation |
| GH-MSK-AI-007 | AI Procurement | Vendor evaluation, diligence, contracting, and contract terms |
| GH-MSK-AI-008 | AI Use Cases | Prioritized MSK specialty use cases with risk tier and evidence needs |
| GH-MSK-AI-009 | AI Implementation | Pilot design, validation, go-live, change control, and scaling |
| GH-MSK-AI-010 | AI Templates | Reusable governance document templates and drafting instructions |
| GH-MSK-AI-011 | AI Checklists | Operational checklists across the full artificial intelligence lifecycle |
| GH-MSK-AI-012 | AI Resources | Authoritative primary sources, standards, and monitoring calendar |
Companion Series Outside the AI Governance Center
| Series | Coverage |
|---|---|
| GoHealthcare Compliance Center | Twelve guide compliance series covering documentation integrity, auditing, and regulatory risk. |
| Prior Authorization Specialty Hub | Thirteen page hub covering musculoskeletal prior authorization operations end to end. |
| Revenue Cycle Knowledge Center | Reimbursement methodology, denial analytics, and revenue integrity. |
| Ambulatory Surgery Center Specialty Hub | Eighteen document set including state regulatory profiles for all fifty states and the District of Columbia. |
| CMS Ambulatory Specialty Model Guide | Operational guide to the mandatory specialty model beginning January 1, 2027 for physical medicine and rehabilitation and the low back pain cohort. |
22
GoHealthcare AI Governance Center
Recommended Downloads and Visual Recommendations
Recommended Downloads
- Artificial Intelligence System Inventory Workbook, structured for the discovery process described in section 5.
- Vendor Artificial Intelligence Disclosure Questionnaire, for the written vendor inquiry that drives discovery.
- Governance Charter Template, including membership, decision rights, and escalation path.
- Risk Tiering Worksheet with the tier definitions used throughout this Center.
- Ninety Day Governance Launch Plan aligned to the sequence in section 5.
- Non-Affirmation Reason Categorization Log for prior authorization analytics.
Visual Recommendations
- Twelve domain wheel showing the sequence and grouping of the Center, using the Center accent color.
- Revenue and authorization cycle map with artificial intelligence touch points overlaid and color coded by risk tier.
- Governance operating model diagram showing the relationship between the board or ownership, the accountable executive, the governance body, and system owners.
- Risk tiering decision tree taking a system from inventory entry to assigned tier.
- Ninety day launch timeline as a horizontal milestone chart.
- Maturity self-assessment scoring visual mapping checked items to entry point.
- Regulatory landscape timeline showing federal and state milestones from January 2025 through the effective date of this document.
23
GoHealthcare AI Governance Center
Pre-Publication Quality Assurance Sign-Off
This document is released subject to the five standing GoHealthcare pre-publication gates. Each gate is confirmed by the responsible reviewer before external publication. Gates that remain open are recorded here rather than omitted.
| Gate | Reviewer of Record | Status |
|---|---|---|
| 1. Clinical and medical reviewer sign-off | Designated clinical reviewer | Open |
| 2. Payer policy currency confirmation | Payer policy analyst | Open |
| 3. WISeR Model status confirmation | Regulatory analyst | Open |
| 4. Legal and counsel review | Retained healthcare counsel | Open |
| 5. Brand and accessibility review | Brand and accessibility reviewer | Open |
Note on gate 5. Confirmed brand hexadecimal codes and logo files have not yet been delivered. The accent color used throughout the AI Governance Center was sampled directly from the client-supplied AI Governance Center graphic. A single-line palette swap is staged in the publishing engine for the moment final brand values are issued.
Back to page navigation24
GoHealthcare AI Governance Center
How is this guidance versioned and maintained?
Original section: Document History
| Version | Date | Change Summary | Approved By |
|---|---|---|---|
| 1.0 | August 6, 2026 | Initial publication. | Pinky Maniri, Founder and CEO of GoHealthcare Practice Solutions |
Material corrections are logged in this table with a version increment rather than a silent edit. Where a correction identified in this document affects another title in the GoHealthcare MSK Specialty Procedure Library, the correction is propagated across affected titles at the time it is logged.
Back to page navigation25
GoHealthcare AI Governance Center
Educational Disclaimer
1. Purpose and Nature of This Document
This document is published by GoHealthcare Practice Solutions as part of the GoHealthcare MSK Specialty Procedure Library and its AI Governance Center. It is intended solely for educational and operational reference purposes for healthcare professionals, practice administrators, utilization management teams, revenue cycle professionals, compliance officers, and healthcare executives. It is not a clinical textbook, a procedural technique manual, a legal opinion, a regulatory filing, or a certification program.
2. No Medical Advice and No Physician Training
Nothing in this document constitutes medical advice or establishes a standard of clinical care. This document does not provide procedural technique instruction, surgical technique instruction, needle placement instruction, medication dosing, or imaging guidance instruction, and it must not be used for
those purposes. All clinical decisions remain the exclusive responsibility of the treating licensed practitioner exercising independent professional judgment with respect to the individual patient.
3. No Legal Advice and No Attorney-Client Relationship
Artificial intelligence law, health information privacy law, nondiscrimination law, corporate practice of medicine doctrine, and insurance regulation vary by jurisdiction and change frequently. Nothing in this document constitutes legal advice, and no attorney-client relationship is created by reading or relying upon it. Organizations must obtain advice from qualified counsel licensed in the applicable jurisdiction before adopting policies, executing vendor agreements, or making regulatory determinations.
4. No Guarantee of Coverage, Payment, or Approval
Coverage positions, prior authorization requirements, utilization management vendor criteria, and payment policies described in this document are summaries prepared for educational purposes. They do not guarantee coverage, prior authorization approval, or payment for any item or service. Benefit determinations depend upon the individual member benefit plan, the applicable contract, the jurisdiction, the date of service, and the clinical documentation submitted.
5. Verification Against Primary Sources Is Required
Every regulatory citation, coverage position, and policy reference in this document was verified against a primary source as of the effective date shown on the cover. Regulations, sub-regulatory guidance, executive orders, litigation outcomes, certification standards, and payer medical policies are subject to change without notice, and several artificial intelligence requirements described here are the subject of active litigation or pending amendment. The reader is responsible for verifying current requirements directly with the issuing authority before acting.
6. Artificial Intelligence Specific Limitations
This document describes governance practices for artificial intelligence used in healthcare operations. It does not validate, certify, endorse, or assess the safety, accuracy, fairness, or regulatory status of any specific artificial intelligence product, model, vendor, or deployment. Organizations remain solely responsible for the selection, validation, monitoring, and use of any artificial intelligence tool, and for the outputs that tool produces within their environment.
7. Human Accountability Is Not Delegable
Nothing in this document supports or authorizes the substitution of artificial intelligence for licensed clinical judgment, for the physician review required in utilization management determinations, or for the professional responsibility of any licensed or otherwise qualified individual. Where federal or state law requires that a qualified human make or own a determination, that requirement is not satisfied by an automated output, regardless of the confidence, accuracy, or sophistication of the system that produced it.
8. Coding and Billing Scope Limitation
Where coding concepts appear in this document, they are presented at an operational and documentation level only. This document does not provide fee schedule amounts, relative value unit values, National Correct Coding Initiative edit tables, Medically Unlikely Edit values, or reimbursement methodology analysis. Current Procedural Terminology is a registered trademark of the American Medical Association. All code sets remain the property of their respective owners and must be licensed and applied from official sources.
9. Authorship and Attribution
This document was developed and published by GoHealthcare Practice Solutions, under the leadership of Pinky Maniri, Founder and CEO of GoHealthcare Practice Solutions. GoHealthcare Practice Solutions is a national Musculoskeletal Specialty Management Services Organization supporting Pain Management, Orthopedic Surgery, Spine Surgery, Neurosurgery, Neuromodulation, Ambulatory Surgery Centers, Sports Medicine, Physical Medicine and Rehabilitation, Podiatry, Rheumatology, and Workers' Compensation.
10. Third Party Content and Trademarks
Payer policy content, utilization management vendor criteria, accreditation standards, and consensus framework material referenced in this document have been synthesized into original language and are not reproduced verbatim. All trademarks, service marks, and policy documents referenced remain the property of their respective owners. Reference to any organization, framework, standard, or product does not imply affiliation, sponsorship, or endorsement in either direction.
11. Case Studies Are Fictional Composites
Any case study appearing in this document is an original educational composite created for instructional purposes. It does not describe any actual patient, practice, health system, payer, vendor, or employee. Any resemblance to an actual person or organization is coincidental and unintended.
12. Privacy and Protected Health Information
This document contains no protected health information. Organizations applying the practices described here remain fully responsible for compliance with the Health Insurance Portability and Accountability Act, the Health Information Technology for Economic and Clinical Health Act, state health privacy law, state consumer privacy law, and all applicable business associate and vendor contract obligations, including obligations that attach when protected health information is disclosed to an artificial intelligence vendor or processed by an artificial intelligence system.
13. No Warranty and Limitation of Liability
This document is provided on an as-is basis without warranty of any kind, whether express or implied, including any implied warranty of accuracy, completeness, merchantability, or fitness for a particular purpose. To the fullest extent permitted by law, GoHealthcare Practice Solutions and its officers, employees, and contributors disclaim liability for any loss, claim, penalty, denial, delay, or damage arising from the use of, or reliance upon, this document.
14. Permitted Use and Redistribution
This document may be used internally by healthcare organizations for education, training, policy development, and operational reference. It may not be resold, rebranded, altered, or redistributed as the work of another party. Attribution to GoHealthcare Practice Solutions and to Pinky Maniri, Founder and CEO of GoHealthcare Practice Solutions, must be retained in any permitted internal reproduction.
15. Currency, Feedback, and Document Control
Readers who identify an error, an outdated citation, or a superseded requirement are encouraged to report it so that a correction can be logged in the Document History and propagated across affected titles in the library. Material corrections are published with a version increment rather than a silent edit. Contact GoHealthcare Practice Solutions through https://www.gohealthcarellc.com.
Summary
GH-MSK-AI-000, Version 1.0. This document is intended for educational and operational reference purposes only. It does not replace physician clinical judgment, payer policy review, legal advice, or official guidance from the Centers for Medicare and Medicaid Services. Coverage policies, artificial intelligence requirements, coding guidance, and reimbursement requirements should always be verified with the applicable payer, regulator, and current regulatory sources.
Developed and published by GoHealthcare Practice Solutions, under the leadership of Pinky Maniri, Founder and CEO of GoHealthcare Practice Solutions.
Website: https://www.gohealthcarellc.com
Back to page navigationBuild a Defensible Healthcare AI Governance Program
GoHealthcare Practice Solutions supports musculoskeletal specialty practices, ambulatory surgery centers, hospitals, and service lines with AI governance, prior authorization, patient access, documentation, revenue cycle, compliance, and operational improvement.
Professional Disclaimer
This material is intended for professional education and operational guidance. It does not replace clinical judgment, official coding publications, payer policies, benefit-plan documents, legal advice, compliance review, or current Centers for Medicare and Medicaid Services guidance. Artificial intelligence law, regulation, accreditation expectations, payer requirements, coverage policies, and technology capabilities change frequently. Verify the live governing source, current effective date, operating jurisdiction, contractual obligations, and patient-specific circumstances before operational reliance.
Nothing in this resource guarantees authorization, coverage, reimbursement, regulatory compliance, certification, a specific clinical outcome, or a specific claim determination. Artificial intelligence must not replace a legally required human determination or physician clinical judgment.
Developed by
GoHealthcare Practice Solutions
Under the leadership of Pinky Maniri, Founder and CEO of GoHealthcare Practice Solutions
Credentials: MSc, BSc, CRCR, CSAPM, CSPPM, CSBI, CSPR, CSAF, Certified in Healthcare AI Governance
This resource reflects more than three decades of healthcare operations experience across pain management, spine, orthopedics, patient access, prior authorization, revenue cycle management, compliance, workforce operations, and healthcare technology.